Illumina, Inc.
(NASDAQ : ILMN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.94%245.371.5%$940.74m
MRNAModerna, Inc. 0.71%144.270.0%$849.73m
REGNRegeneron Pharmaceuticals, Inc. 0.84%612.492.6%$526.18m
VRTXVertex Pharmaceuticals, Inc. 3.19%292.551.9%$516.29m
GILDGilead Sciences, Inc. 0.80%63.081.0%$513.27m
NVAXNovavax, Inc. -0.27%51.6775.7%$422.21m
ILMNIllumina, Inc. 0.20%193.933.3%$361.41m
BIIBBiogen, Inc. 0.26%211.931.8%$242.32m
SNSSSunesis Pharmaceuticals, Inc. 9.63%2.960.7%$206.91m
CRSPCRISPR Therapeutics AG 2.78%66.960.6%$173.29m
BNTXBioNTech SE 1.32%134.040.0%$153.17m
BMRNBioMarin Pharmaceutical, Inc. 2.72%86.854.2%$121.28m
EXASEXACT Sciences Corp. 6.89%45.1517.7%$107.32m
IOVAIovance Biotherapeutics, Inc. 0.19%10.350.0%$103.94m
TECHBio-Techne Corp. 2.16%352.764.5%$95.22m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.